<DOC>
	<DOCNO>NCT01112189</DOCNO>
	<brief_summary>The post-mastectomy lymphedema complication removal breast nodal plexus cause accumulation lymph subsequent enlargement upper limb . It common complication attributable mastectomy axillary dissection occur one third patient undergo radical mastectomy radiotherapy post-operation . Currently treatment lymphedema upper limb mainly use compression stocking , use pneumatic compression pump physiotherapy . Multiple report indicate endothelial progenitor cell ( EPC ) differentiate various cell line , reproduce participate neoangiogenesis . This study conduct General Surgery Service , Hospital Universitario `` Dr. José Eleuterio González `` propose EPC obtain autologous transplantation bone marrow treatment postoperative lymphedema upper limb follow axillary lymphadenectomy stimulation lymphatic neoangiogenesis . The investigator study 20 female patient 18 year axillary lymphadenectomy . The objective develop innovative definitive treatment patient analyze cost complication treatment may .</brief_summary>
	<brief_title>Use Stem Cells Lymphedema Post Mastectomy</brief_title>
	<detailed_description>Phase 1 : The procedure follow : 10 patient recruit General Surgery Oncology meeting inclusion criterion . During study , patient can´t use kind treatment lymphedema . Visit 1 : We explain procedure invite patient participate signing informed consent . There complete medical history , review inclusion exclusion criterion , sign letter inform consent , request general laboratory test ( blood count , biochemical profile ) , tele-ray . Visit 2 : Initiation colony stimulate factor ( Filgrastim SC ) 300 microgram per day 3 consecutive day . Visit 3 : Conduct puncture bone marrow harvest local anesthesia posterior iliac crest Jamshidi needle aspirate ( approximately 50 - 100ml ) . The product obtain centrifuge refrigerate centrifuge 3500 Sigma EK15 ® rpm/15 minute 8 ° C HES 6 % ( pentastarch 6g/100ml ) obtain mononuclear cell layer . Once cell obtain transported operating room manage patient intramuscular injection 0.5 1 ml 30 50 site affect limb depth one centimeter , use needle number 25 . The administration take place operate room local anesthesia sedation necessary . Visit 4 subsequent : clinical evaluation conduct week , especially data monitor infection puncture sit . At week 12 post-cell infusion , late revision make carried measurement arm conclude determine outcome treatment . Phase 2 ( Control group ) : Another 10 patient lymphedema include 6 week study compare common treatment lymphedema , compress sleeve . Visit 1 : A complete medical history perform . A compression sleeve give patient use next 2 week . Visit 2 3 : On week 2 3 compression sleeve treatment , patient measure upper extremity well assess symptoms patient present . Visit 4 5 : Patients stop use compression sleeve treatment next 2 week measure upper extremity interrogate patient symptoms period . Visit 6 7 : The last 2 week study patient ask restart compress sleeve treatment measure upper extremity interrogate patient symptom present stage study .</detailed_description>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>Inclusion criterion : Patients postsurgical lymphedema upper extremity follow axillary lymphadenectomy . Female gender . Age 18 year . Patients wish participate study . Informed consent sign . Exclusion criterion : Patients hypercoagulable state . Patients history obstructive vascular disease brain , kidneys heart . Patients congestive heart failure ( ejection fraction le 30 % ) Active infectious process , serious , anywhere body . Patients 75 year age .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Lymphedema</keyword>
	<keyword>Stem cell</keyword>
	<keyword>Mastectomy</keyword>
	<keyword>Breast Cancer</keyword>
</DOC>